Formulation and evaluation of physical stability and antidiabetic activity from nanoliposomes containing an ethyl acetate extract of Solanum xanthocarpum Schrader & Wendland fruit in rats

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 50

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_HERM-13-4_008

تاریخ نمایه سازی: 16 مهر 1403

چکیده مقاله:

Introduction: The extract of Solanum xanthocarpum fruit has antidiabetic activity. This research aims to formulate nanoliposomes containing ethyl acetate extracts of S. xanthocarpum selected from multilevel extraction, evaluate their physical stability and antidiabetic activity, and compare them with the extract. Methods: The extracts were prepared using n-hexane, ethyl acetate, ethanol, and water as solvents, and their antidiabetic activities were evaluated to select the extract most effective in lowering blood sugar levels in rats. That extract was formulated into three nanoliposomes using varying amounts of phospholipid, cholesterol, and Span ۶۰, i.e., F۱ (۴۰ mmol), F۲ (۵۰ mmol), and F۳ (۶۰ mmol). Various sonication times ranging from ۱۰ to ۳۰ minutes were evaluated for particle size, entrapment efficiency, and physical stability. The selected formulations were evaluated for antidiabetic activity. Results: The ethyl acetate extract showed the highest decrease in glucose in rats and was selected for nanoliposome formulation. The nanoliposomes obtained were physically stable at low temperatures for ۱۲ weeks. F۲ had the smallest particle size (۱۴۳.۹۷ nm) and the greatest entrapment efficiency (۹۲.۹۸۱% ± ۰.۳۵%) with a sonication time of ۳۰ minutes and was significantly different from F۱ and F۳ (P<۰.۰۵). The highest percentage reduction in blood sugar levels was with F۲ at ۷۴.۵۷% and significantly differed (P<۰.۰۵) from the ethyl acetate extract of S. xanthocarpum at ۷۳.۹۸% and the positive control rat group. Conclusion: The results show the potential uses of the prepared nanoparticles, especially the F۲ formulation, as an antidiabetic formula.